Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2665-9913(20)30008-4
PubMed Identifier: 32280950
Publication URI: http://europepmc.org/abstract/MED/32280950
Type: Journal Article/Review
Volume: 2
Parent Publication: The Lancet. Rheumatology
Issue: 3
ISSN: 2665-9913